These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23035179)

  • 1. Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men.
    Epplein M; Zheng W; Xiang YB; Peek RM; Li H; Correa P; Gao J; Michel A; Pawlita M; Cai Q; Shu XO
    Cancer Epidemiol Biomarkers Prev; 2012 Dec; 21(12):2185-92. PubMed ID: 23035179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori blood biomarker for gastric cancer risk in East Asia.
    Cai H; Ye F; Michel A; Murphy G; Sasazuki S; Taylor PR; Qiao YL; Park SK; Yoo KY; Jee SH; Cho ER; Kim J; Chen SC; Abnet CC; Tsugane S; Cai Q; Shu XO; Zheng W; Pawlita M; Epplein M
    Int J Epidemiol; 2016 Jun; 45(3):774-81. PubMed ID: 27170766
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Varga MG; Wang T; Cai H; Xiang YB; Gao YT; Ji BT; Pawlita M; Waterboer T; Zheng W; Shu XO; Epplein M
    Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):342-344. PubMed ID: 29263184
    [No Abstract]   [Full Text] [Related]  

  • 4. Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case-control Study.
    Fernández de Larrea-Baz N; Pérez-Gómez B; Michel A; Romero B; Lope V; Pawlita M; Fernández-Villa T; Moreno V; Martín V; Willhauck-Fleckenstein M; López-Abente G; Castilla J; Fernández-Tardón G; Dierssen-Sotos T; Santibáñez M; Peiró R; Jiménez-Moleón JJ; Navarro C; Castaño-Vinyals G; Kogevinas M; Pollán M; de Sanjosé S; Del Campo R; Waterboer T; Aragonés N
    Cancer Epidemiol; 2017 Oct; 50(Pt A):76-84. PubMed ID: 28888185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prospective Study of Urinary Prostaglandin E2 Metabolite, Helicobacter pylori Antibodies, and Gastric Cancer Risk.
    Wang T; Cai H; Zheng W; Michel A; Pawlita M; Milne G; Xiang YB; Gao YT; Li HL; Rothman N; Lan Q; Shu XO; Epplein M
    Clin Infect Dis; 2017 May; 64(10):1380-1386. PubMed ID: 28402440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori seroprevalence in Spain: influence of adult and childhood sociodemographic factors.
    Lorenzo I; Fernández-de-Larrea N; Michel A; Romero B; Lope V; Bessa X; Moreno V; Martín V; Amiano P; Castilla J; Tardón A; Dierssen-Sotos T; Peiró R; Díaz-Santos M; Navarro C; Jiménez-Moleón JJ; Butt J; Barricarte A; Ruiz I; Molina-de-la-Torre AJ; Casabonne D; Pérez-Gómez B; Kogevinas M; Del Campo R; de Sanjosé S; Pollán M; Waterboer T; Aragonés N
    Eur J Cancer Prev; 2019 Jul; 28(4):294-303. PubMed ID: 30489354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort.
    Murphy G; Freedman ND; Michel A; Fan JH; Taylor PR; Pawlita M; Qiao YL; Zhang H; Yu K; Abnet CC; Dawsey SM
    Int J Cancer; 2015 Oct; 137(8):1938-46. PubMed ID: 25845708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.
    Song H; Michel A; Nyrén O; Ekström AM; Pawlita M; Ye W
    Int J Cancer; 2014 Jun; 134(12):2942-50. PubMed ID: 24259284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The U-shaped association between body mass index and gastric cancer risk in the Helicobacter pylori Biomarker Cohort Consortium: A nested case-control study from eight East Asian cohort studies.
    Jang J; Wang T; Cai H; Ye F; Murphy G; Shimazu T; Taylor PR; Qiao YL; Yoo KY; Jee SH; Kim J; Chen SC; Abnet CC; Tsugane S; Zheng W; Shu XO; Pawlita M; Park SK; Epplein M
    Int J Cancer; 2020 Aug; 147(3):777-784. PubMed ID: 31745972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet, Helicobacter pylori strain-specific infection, and gastric cancer risk among Chinese men.
    Epplein M; Zheng W; Li H; Peek RM; Correa P; Gao J; Michel A; Pawlita M; Cai Q; Xiang YB; Shu XO
    Nutr Cancer; 2014; 66(4):550-7. PubMed ID: 24666234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males.
    Song M; Camargo MC; Weinstein SJ; Murphy G; Freedman ND; Koshiol J; Stolzenberg-Solomon RZ; Abnet CC; Männistö S; Albanes D; Rabkin CS
    Aliment Pharmacol Ther; 2018 Feb; 47(4):494-503. PubMed ID: 29243850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating cytokines and gastric cancer risk.
    Epplein M; Xiang YB; Cai Q; Peek RM; Li H; Correa P; Gao J; Wu J; Michel A; Pawlita M; Zheng W; Shu XO
    Cancer Causes Control; 2013 Dec; 24(12):2245-50. PubMed ID: 24052422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori infection and risk of gastric cancer in Shanghai, China: updated results based upon a locally developed and validated assay and further follow-up of the cohort.
    Yuan JM; Yu MC; Xu WW; Cockburn M; Gao YT; Ross RK
    Cancer Epidemiol Biomarkers Prev; 1999 Jul; 8(7):621-4. PubMed ID: 10428200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study.
    Palli D; Masala G; Del Giudice G; Plebani M; Basso D; Berti D; Numans ME; Ceroti M; Peeters PH; Bueno de Mesquita HB; Buchner FL; Clavel-Chapelon F; Boutron-Ruault MC; Krogh V; Saieva C; Vineis P; Panico S; Tumino R; Nyrén O; Simán H; Berglund G; Hallmans G; Sanchez MJ; Larrãnaga N; Barricarte A; Navarro C; Quiros JR; Key T; Allen N; Bingham S; Khaw KT; Boeing H; Weikert C; Linseisen J; Nagel G; Overvad K; Thomsen RW; Tjonneland A; Olsen A; Trichoupoulou A; Trichopoulos D; Arvaniti A; Pera G; Kaaks R; Jenab M; Ferrari P; Nesi G; Carneiro F; Riboli E; Gonzalez CA
    Int J Cancer; 2007 Feb; 120(4):859-67. PubMed ID: 17131317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
    Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR
    J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology.
    Gao L; Michel A; Weck MN; Arndt V; Pawlita M; Brenner H
    Cancer Res; 2009 Aug; 69(15):6164-70. PubMed ID: 19602590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori protein-specific antibodies and risk of colorectal cancer.
    Epplein M; Pawlita M; Michel A; Peek RM; Cai Q; Blot WJ
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1964-74. PubMed ID: 24045925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States.
    Butt J; Varga MG; Blot WJ; Teras L; Visvanathan K; Le Marchand L; Haiman C; Chen Y; Bao Y; Sesso HD; Wassertheil-Smoller S; Ho GYF; Tinker LE; Peek RM; Potter JD; Cover TL; Hendrix LH; Huang LC; Hyslop T; Um C; Grodstein F; Song M; Zeleniuch-Jacquotte A; Berndt S; Hildesheim A; Waterboer T; Pawlita M; Epplein M
    Gastroenterology; 2019 Jan; 156(1):175-186.e2. PubMed ID: 30296434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological response to Helicobacter pylori infection among Latin American populations with contrasting risks of gastric cancer.
    Camargo MC; Beltran M; Conde-Glez CJ; Harris PR; Michel A; Waterboer T; Carolina Flórez A; Torres J; Ferreccio C; Sampson JN; Pawlita M; Rabkin CS
    Int J Cancer; 2015 Dec; 137(12):3000-5. PubMed ID: 26178251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China.
    Limburg P; Qiao Y; Mark S; Wang G; Perez-Perez G; Blaser M; Wu Y; Zou X; Dong Z; Taylor P; Dawsey S
    J Natl Cancer Inst; 2001 Feb; 93(3):226-33. PubMed ID: 11158192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.